The outlook of companies tied to flagship drugs like Viagra presents a challenging investment landscape . While the initial boom of copyright, fueled by Viagra's extraordinary popularity, generated substantial profits , the expiry in key markets has introduced considerable risk . Investors are now assessing the impact of generic competition , dimin